Cerubidine (Daunorubicin) Patient Information: How Should I Take the Drug at RxList

Pill Identifier Search

May 26, 2012

Cerubidine

Leukemia »

Leukemia facts

Leukemia is a cancer of the blood cells.
While the exact cause(s) of leukemia is not known, risk factors have been identified.
Leukemias are grouped by how quickly the disease develops (acute or chronic) as well as by the type of blood cell that is affected (lymphocytes or myelocytes). The four main types of leukemia include acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML), and chronic myelocytic leukemia (CML).
People with leukemia are at significantly increased risk for developing infections, anemia, and bleeding. Other symptoms and signs include easy bruising, weight loss, night sweats, and unexplained fevers.
The diagnosis of leukemia is supported by findings of the medical history and examination, and examining blood and bone marrow samples under a microscope.
Tre...

Read the Leukemia article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Cerubidine

Breast Cancer Slideshow Pictures

Pancreatic Cancer Slideshow Pictures

Skin Cancer Slideshow Pictures

font size

Cerubidine Patient Information including How Should I Take

What should I discuss with my healthcare provider before using daunorubicin (Cerubidine)?

Do not use daunorubicin without first talking to your doctor if you have

kidney disease;
liver disease;
heart disease;
poor bone marrow function;
received radiation therapy that encompassed the heart; or
previously received treatment with doxorubicin (Adriamycin, Rubex), doxorubicin liposomal (Doxil), daunorubicin (Cerubidine), daunorubicin liposomal (DaunoXome), idarubicin (Idamycin), or mitoxantrone (Novantrone).

The use of daunorubicin may be dangerous if you have any of the conditions listed above.

Daunorubicin is in the FDA pregnancy category D. This means that daunorubicin is known to be harmful to an unborn baby. Do not use daunorubicin without first talking to your doctor if you are pregnant. Discuss with your doctor the appropriate use of birth control during treatment with daunorubicin if necessary.

Daunorubicin passes into breast milk and may harm a nursing baby. Breast-feeding should be avoided during treatment with daunorubicin.

Children have an increased risk of heart problems due to treatment with daunorubicin. Growth and gonadal development may also be affected.

How should I use daunorubicin (Cerubidine)?

Daunorubicin should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Your doctor will determine the correct amount and frequency of treatment with daunorubicin depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.

Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with daunorubicin to monitor progress and side effects.

Skin accidentally exposed to daunorubicin should be rinsed thoroughly with soap and warm water.

Your healthcare provider will store daunorubicin as directed by the manufacturer. If you are storing daunorubicin at home, follow the directions provided by your healthcare provider.

Related Drug Centers